# We will not take up marijuana in the House. The Senate can take it up, pass it, send it to us … > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-federal-legalization-uncertainty-clinical-impact/ > **Published:** 2026-04-24T23:11:53-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:02:41-04:00 > **Clinical Summary:** Explore cannabis federal legalization uncertainty and its impact on clinical practice and patient care amid evolving state laws and regulatory challenges. --- ✦ New CED Clinical Relevance #15 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyIndustry Clinical Perspective While federal legalization of cannabis remains politically uncertain and unlikely to advance in the House in the near term, clinicians should remain aware that cannabis use is already legal in most states and increasingly normalized in patient populations. The disconnect between federal Schedule I status and state-level legalization creates a complex clinical landscape where providers must navigate conflicting legal frameworks, limited clinical evidence, and patients’ own varying assumptions about safety and legality. This regulatory gridlock also impedes research progress, making it difficult for clinicians to access high-quality evidence on efficacy, optimal dosing, and long-term safety for specific conditions. Regardless of federal policy trajectory, providers should proactively assess cannabis use in patient histories, understand their state’s legal framework and [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) programs, and counsel patients using an evidence-based approach that acknowledges both potential symptom relief in select conditions and documented risks—particularly for [adolescent brain development](https://cedclinic.com/adolescent-cb1-receptor-antagonism-social-behavior/), driving safety, and cannabis use disorder—while docum 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20%22We%20will%20not%20take%20up%20%3Cb%3Emarijuana%3C%2Fb%3E%20in%20the%20House.%20The%20Senate%20can%20take%20it%20up%2C%20pass%20it%2C%20send%20it%20to%20u...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fwe-will-not-take-up-marijuana-in-the-house-the-senate-can-take-it-up-pass-it-send-it-to-us%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fwe-will-not-take-up-marijuana-in-the-house-the-senate-can-take-it-up-pass-it-send-it-to-us%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20%22We%20will%20not%20take%20up%20%3Cb%3Emarijuana%3C%2Fb%3E%20in%20the%20House.%20The%20Senate%20can%20take%20it%20up%2C%20pass%20it%2C%20send%20it%20to%20u...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fwe-will-not-take-up-marijuana-in-the-house-the-senate-can-take-it-up-pass-it-send-it-to-us%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence State House Committee Approves Six Attorney General Bills – South Dakota State News Review recent legislative actions impacting cannabis policy and enforcement in South Dakota, highlighting ongoing regulatory developments. Read More [Farmer drags gov’t to Supreme Court over ‘extortionate fees’ and ‘restrictive licensing’ for …](https://cedclinic.com/2026-cannabis-licensing-fees-regulatory-challenges/) Explore a significant legal challenge addressing cannabis licensing fees and regulatory barriers affecting industry stakeholders. [Learn More](https://cedclinic.com/2026-cannabis-licensing-fees-regulatory-challenges/) [DCCC faces pushback from Democratic candidates for tipping the primary scales](https://cedclinic.com/dccc-primary-election-influence-candidate-pushback/) Understand political dynamics influencing cannabis policy discussions within party primaries and legislative priorities. [Discover More](https://cedclinic.com/dccc-primary-election-influence-candidate-pushback/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).